Merck KGaA has created a committee of renowned experts to advise it on bioethical matters.
The Merck Bioethics Advisory Panel will provide recommendations on how to take bioethical aspects into consideration when discovering and developing new products and processes.
Three American, two German and one Swiss professor will sit on the panel and support Merck in addressing related topics, such as integrity, sustainability and legal compliance.
Biotechnological and biomedical research is an important factor for Merck. Last year, its Merck Serono division generated 61% of its sales with its top five selling biopharmaceuticals.
The panel of experts includes: Professor Dena S. Davis, Professor Jeanne Loring, Professor Jeremy Sugarman, Professor Jochen Taupitz, Professor Nikolaus Knoepffler and Professor Christoph Rehmann-Sutter.